[1]
E. . Gonzalez, M. . Bui, and A. Ahmed, “IGF1R immunohistochemistry in Ewing’s sarcoma as predictor of response to targeted therapy”, IJHS, vol. 14, no. 4, pp. 17–21, Jun. 2020.